Provectus Biopharmaceuticals, Inc.

Release Summary

PROVECTUS BIOPHARMACEUTICALS UPDATES MARKET ON BUSINESS DEVELOPMENTS Enrollment Open for Phase 3 PV-10 Melanoma Study Patent Protections Expanded in Europe and Japan

Provectus Biopharmaceuticals, Inc.